The rejected bids are for papaverine hydrochloride 60mg in 2ml capsules. The first offer was for Rs. 73,000 per ampule. The TEC rejected it and recommended for Yaden to re-tender. It did so in May ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

Eric J. Fues and Kyle W. Howarth of Finnegan address the on-sale bar in patent law, with a focus on how pre-filing sales of ...

The National Agency for Food and Drug Administration and Control has alerted the public on falsified Oxycontin 80mg ...

Dublin: BrePco Biopharma Limited (BPCO) that develops products for the unique needs of paediatric patients and Piramal ...

The Food and Drug Administration (FDA) has expanded the list of medicines for non-communicable diseases (NCDs) exempted from ...

Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...

Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.